Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157
The molecule was first identified and studied by the Sikiric research group in Croatia starting in the early 1990s, and the bulk of the preclinical evidence base comes from more than three decades of rat and rodent studies showing consistent tissue-repair, anti-inflammatory, and gastroprotective effects
Norwood K, Wang RY, Hirschmann-Jax C, Andreeff M , Brenner MK, Goodell MA, Wulf GG
L-Glutathione reduced Based on 56 publication(s) in Google Scholar L-Glutathione reduced (GSH
I almost always see depleted levels in my patients with chronic diseases
This bypasses the typical "gatekeepers" of digestion that often degrade standard supplements